Medindia

X

Winner Medical Announces the Opening of Additional Six PurCotton(R) Chain Stores in Shenzhen, China

Wednesday, April 21, 2010 General News J E 4
Advertisement
SHENZHEN, China, April 20 Winner Medical Group Inc.(Nasdaq: WWIN) ("Winner," or "the Company"), a leading manufacturer of medicaldressings, medical disposables and non-woven PurCotton(R) materials for themedical and consumer products industries, announced today that since January 1,2010, it has opened nine PurCotton(R) chain stores, and an additional eightnew stores will be opened by the end of April in Shenzhen, Guangdong province,China.

In December 2009, Winner's subsidiary Winner Industries (Shenzhen) Co.,Ltd. established a wholly owned subsidiary, Shenzhen PurCotton Technology Co.,Ltd. to develop sales channels in the China marketplace and sell itsPurCotton(R) branded products. PurCotton(R) is a non-woven fabric made with100% natural cotton products. PurCotton promotes the concept of "Let medicalproducts close to your life, Let pure cotton take care of your health." UsingPurCotton(R) patented technology, the company develops many healthy,comfortable, safe and environmentally friendly daily care and home livingproducts. PurCotton(R) products are classified into four main categories: babypersonal products, feminine personal products, daily home care products andmedical care products. The raw materials of all PurCotton(R) products areimported from the United States, are natural cotton and additive-free. Theaverage total cost of each store, with sizes ranging from 50 to 100 squaremeters, is approximately $40,000 to $60,000, which includes the lease,build-out, one month's salary for salespeople and inventory stocking.

PurCotton(R) enters into a niche market by promoting medical products fordaily use. The main distribution channels will be chain stores (PurCotton(R)stores), on-line sales, supermarkets and wholesales to large customers, whilepromoting the concept of high quality life by using pure cotton products.PurCotton(R) stores are mainly located in downtown shopping malls and high-endcommunities with high visibility and significant foot traffic. ShenzhenPurCotton Technology Co., Ltd. employs professional retailing and brandbuilding consultants to advocate the concept of a healthy life. On April 15,2010, Winner Medical entered into an employee agreement with Mr. Zihan Wu, whowas appointed general manager of Shenzhen PurCotton Technology Co., Ltd. Mr.Wu graduated from Wuhan University with majors in Economic Management andComputer Science. He has solid experience in Internet and media businessesfrom when he was a partner of Shanghai Angel Venture Capital ManagementCompany. Mr. Wu's strong e-commerce experience will assist the Company'sefforts in building PurCotton(R) business-to-consumer online stores in orderto better meet consumer's diversified shopping requirements.

About Winner Medical:

Winner Medical is a leading manufacturer and the largest exporter byvolume in the medical dressing industry in China. Headquartered in Shenzhen,the Company has eight wholly owned operating subsidiaries and four jointventures with over 5,000 employees. The Company engages in the manufacturing,sale, research and development of medical care products, wound care products,home care products and PurCotton(R) products, a non-woven fabric made from100% natural cotton. The products are sold worldwide, with Europe, the UnitedStates, China and Japan serving as the top four markets. The Company currentlyholds more than sixty patents and patent applications for various products andmanufacturing processes and is one of the few Chinese companies licensed bythe U.S. Food and Drug Administration (FDA) to ship finished, sterilizedproducts directly to the United States market. To learn more about WinnerMedical, please visit Winner Medical's web site at:http://ir.winnermedical.com .

Forward-Looking Statements:

This press release contains certain statements that may include"forward-looking statements" within the meaning of Section 27A of theSecurities Act of 1933, as amended, and Section 21E of the Securities ExchangeAct of 1934, as amended. All statements, other than statements of historicalfact included herein are "forward-looking statements" including statementsregarding Winner Medical and its subsidiary companies' business strategy,plans and objective and statements of non-historical information. Theseforward-looking statements are often identified by the use of forward-lookingterminology such as "believes," "expects" or similar expressions, involveknown and unknown risks and uncertainties. Although Winner Medical believesthat the expectations reflected in these forward-looking statements arereasonable, they do involve assumptions, risks and uncertainties, and theseexpectations may prove to be incorrect. You should not place undue reliance onthese forward-looking statements, which speak only as of the date of thispress release. Winner Medical's actual results could differ materially fromthose anticipated in these forward-looking statements as a result of a varietyof factors, including those discussed in Winner Medical's periodic reportsthat are filed with and available from the Securities and Exchange Commission.All forward-looking statements attributable to Winner Medical or personsacting on its behalf are expressly qualified in their entirety by thesefactors. Other than as required under the securities laws, Winner Medical doesnot assume a duty to update these forward-looking statements.For more information, please contact: Company: Peng Zhai Investor Relations Manager Winner Medical Group Inc. Tel: +86-755-2806-6858 +86-755-2813-8888 x691 Email: investors@winnermedical.com Web: http://ir.winnermedical.com Investors: Scott Powell HC International, Inc. Tel: +1-917-721-9480 Email: scott.powell@hcinternational.net Web: http://www.hcinternational.net

SOURCE Winner Medical Group Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Mersana Therapeutics Presents Data Demonstrating X...
S
CVS Caremark Patient Survey Finds Specialty Pharma...